A perspective from inside the industry · 40+ Years

Healthcare is at
an inflection point.
Most of the industry
hasn't noticed.

AI is not a feature to add to next year's roadmap. It is a structural shift that changes what patients can expect from medicine — and what medicine has left to excuse. The data is in. The architecture exists. What remains is a leadership decision.

Read the Case → Start a Conversation
The Problem
44,000–98,000 Americans die annually from preventable hospital errors — more than motor vehicle accidents
The Gap
86% of health organizations use AI today — the vast majority for scheduling and billing, not clinical outcomes
The Shift
Healthcare AI adoption jumped 6× in a single two-week window in January 2025 — the inflection point has arrived
The Opportunity
AI-enabled med tech is a $14B market today, projected to exceed $255B by 2033 — led by whoever moves first
The Perspective Here
40 years building connected medication management platforms — including 1M+ infusion pumps integrated to the EMR
The Core Argument

Med tech is running out of time.
So are the excuses.

Read the full LinkedIn article ↗ — LinkedIn login may be required

Preventable medication errors kill more Americans each year than motor vehicle accidents. Sepsis remains one of the leading causes of in-hospital death — despite the fact that AI systems are already demonstrating the ability to identify it hours earlier than clinical teams. Healthcare AI adoption has crossed its inflection point. The industry that should be leading this shift is largely still debating whether to start.

98,000 Americans die annually from preventable hospital errors — surpassing motor vehicle fatalities
StatPearls / Institute of Medicine, 2024
$42B estimated annual global cost of medication errors alone — not counting lost productivity or disability
World Health Organization, 2024
6× surge in healthcare AI adoption rate — in a single two-week window, January 2025
U.S. Census Bureau / JAMA Network Open, 2025
Playing it safe is not safe anymore. The patients who depend on these systems cannot afford to wait for the next integration cycle.
Where We Are

An industry that traded
innovation for acquisition.

The dominant narrative in med tech for the past two decades has not been transformation — it has been consolidation. Companies make transformative acquisitions, promise integrated platforms, then spend three years rationalizing the portfolio while the patients who depend on these systems wait.

Pfizer, ICU Medical, BD, Baxter — the pattern is consistent. Resources that should fund next-generation platforms get consumed by remediation. Institutional knowledge disperses. Legacy hardware accumulates. The bold connected strategy that was once the product roadmap becomes a footnote.

The stock charts tell the story the press releases will not. When a company retreats to defense — managing liability, protecting legacy revenue — it stops creating value. Eventually, so does everyone else.

What Is Possible Now

AI doesn't
improve the roadmap.
It rewrites it.

01
Real-Time Clinical Decision Support AI embedded in infusion systems detecting dosing anomalies before harm occurs — not after a recall is filed.
02
Predictive Failure Detection Device telemetry analyzed continuously to flag failure weeks before it reaches the patient — or the FDA.
03
Natural Language Clinical Interface Nurses interacting with medication systems the way they interact with their phones — not navigating eight-screen workflows.
04
Closed-Loop Autonomous Delivery Already proven in diabetes. The architecture scales to acute care. The will to build it has been the only missing ingredient.
05
Sepsis Early Warning LLMs trained on anonymized patient data identifying sepsis onset hours before standard clinical recognition. The data exists. It is not being used.
Daniel C. Pettus
Daniel C. Pettus
Healthcare Informatics Executive · Advisor · Inventor
BD / CareFusion iMetrikus Alaris AAMI IHE PCD 2× Patent BI&T Award
The Story

1999. Carlsbad, California. The Future Was Not Waiting.

I joined a startup called iMetrikus and we built something the world had never seen: a secure, cloud-based personal health record platform with remote medical device connectivity — for consumers, at home, over the internet. This was not a pilot. This was production. This was 2001.

The MetrikLink® gateway let home-based medical devices communicate with a central health record. We were not waiting for a committee's permission. We were building the future.

Building the Category Leader

Moving to Alaris, then CareFusion, then BD, I carried that same urgency. We launched the Alaris® Server and wireless networked infusion applications. We grew acute-care infusion market share from 25% to over 60%. We connected more than one million infusion pumps to the electronic medical record. The technology was not theoretical — it was deployed, saving lives, and working.

In 2011, I convened 40 of the world's leading experts in infusion therapy and healthcare IT in San Diego. The clinical evidence was unambiguous. The roadmap was clear. The architecture was ready.

Career Timeline

1999–2003
Co-Founder / VP · iMetrikus Pioneer cloud-based PHR with remote device connectivity. MetrikLink® consumer gateway.
2003–2009
VP Product & Connectivity · Alaris / Cardinal Health Launched Alaris® Server. Grew acute-care market share from 25% → 60%+.
2009–2015
VP Strategy & Innovation · CareFusion Connectivity Summit 2011. HIC Brisbane 2017. 1M+ pumps connected to EMR.
2015–2019
VP · Becton Dickinson Post-CareFusion acquisition. Continued EMR integration strategy. Retired 2019.
2019 – Present
Executive Advisor & Board Candidate Strategic advisory, thought leadership, and select board engagements in med tech and connected health.
How I Can Help

The right problem
deserves the deepest
expertise available.

After 40 years building connected medication management platforms, I engage selectively — with organizations at genuine inflection points where deep domain experience and a clear strategic point of view can change the outcome. If that describes what you are working on, it is worth a conversation.

🏛
Board Membership
Strategic governance for med tech, digital health, and connected care companies at inflection points. I bring four decades of operational depth, clinical credibility, and a clear point of view on where this industry must go.
Selective · High-impact only
🎯
Strategic Advisory
AI adoption roadmaps, platform strategy, regulatory navigation, and competitive positioning for established players reinventing themselves — and new entrants building from first principles.
Engagements · Retained advisory
💡
Investment Advisory
Due diligence and market validation for investors entering the AI-enabled med tech space. The infusion therapy and connected medication management market is structurally ripe for disruption. I can tell you exactly where, and why, and what the clinical evidence says.
VC · PE · Family Office
A Global Perspective

The shift to AI-enabled healthcare
is not uniquely an American challenge.

The problems this site is built around — preventable medication errors, alarm fatigue, reactive care delivery — are not confined to any single health system. They are the shared cost of an industry that built technology to document care rather than improve it, in every country that adopted that model.

What makes the current moment interesting is that the path forward is being pursued with different urgency in different markets. Australia has made a deliberate national commitment to digital health infrastructure that is worth watching. The Australian Digital Health Agency's National Digital Health Strategy 2023–2028 is not a policy document — it is a funded, operational roadmap, with My Health Record now serving nearly all Australians and AI integration named as a national priority.

The Australian Government's 2024–25 Budget included a specific review of healthcare law to ensure AI governance frameworks keep pace with clinical deployment. That is a government getting ahead of the technology, not scrambling to catch up with it. The models being built and tested in the Australian system — population-scale digital records, AI embedded in clinical workflows, virtual care as a standard-of-care option — are worth studying wherever connected health reform is on the agenda.

Conference Presentation · Brisbane, Australia
Connected Medication Management Strategy — End-to-End Platform Architecture
HIC Health Informatics Conference · August 2017
Hosted by the Health Informatics Society of Australia (HISA) · 150+ speakers · 1,000+ delegates

This poster presentation outlined the connected medication management architecture that had been built and deployed at scale — linking infusion pumps, pharmacy, and the EMR into a closed-loop clinical workflow. The session drew strong interest from Australasian clinicians and health system leaders. The response confirmed what the data had already shown: the roadmap was sound, the will to build it was the variable.
View HIC 2017 Conference ↗
🏛
National Digital Health Strategy 2023–2028
Australia's Australian Digital Health Agency is executing a funded, multi-year national roadmap — not a pilot program. My Health Record already covers the vast majority of the population. AI integration, interoperability, and virtual care are named operational priorities, not aspirations.
⚖️
Proactive AI Governance
The Australian Government funded a dedicated review of healthcare law in 2024–25 to ensure AI governance frameworks keep pace with clinical deployment. That kind of deliberate policy architecture — getting the rules right before the rollout scales — is the less visible work that determines whether AI adoption succeeds long-term.
🌏
What the Rest of the World Can Learn
Every health system is wrestling with the same transition. What distinguishes the leaders is not the technology — it is the institutional will to move from coordination to prediction. The connected foundation is in place. The clinical evidence is in. The next step is a leadership decision, here and everywhere.
📋
Upcoming: AI.Care 2026, Melbourne — A presentation has been submitted to the Australasian Institute of Digital Health's AI.Care conference (November 2026) proposing a session titled The Dark Cockpit: A Future Where AI Sits at the Core of Care, Not at Its Edge. The session draws on the connected medication management architecture presented at HIC Brisbane in 2017 and makes the case for AI as the clinical reasoning engine — not a feature layered onto existing systems. Acceptance pending.
AI Predictive Care — The Vision

What the shift looks like
in clinical practice.

The following diagram is based on research presented at the CareFusion Connectivity Summit (San Diego, 2011) and the HIC Health Informatics Conference (Brisbane, 2017). It describes not what is theoretical — but what the connected architecture makes possible today.

Published Work

The argument has been
documented for decades.

Peer-reviewed journals, conference proceedings, and industry standards contributions spanning 20+ years.

2025 · LinkedIn Article — Latest
Med Tech Is Running Out of Time. So Are the Excuses.
The case for AI-enabled transformation in medication management — the argument this site is built around, in full.
Read on LinkedIn ↗ LinkedIn login may be required
2014 · Best Article of the Year
Worth the Effort? Closed-Loop Infusion Pump Integration with the EMR
Biomedical Instrumentation & Technology, BI&T/AAMI · with T. Vanderveen
2014
Reliable and Scalable Infusion System Integration with the Electronic Medical Record
Biomedical Instrumentation & Technology · with Vanderveen, Canfield, Schad
2011
Where IT Meets IV: Integrating Intravenous Infusion Devices with Hospital Information Systems
BI&T/AAMI · with T. Vanderveen
2011
IV Infusion Pump Wireless Connectivity: Development, Current Status and Requirements for Success
Proceedings, 11th CareFusion Connectivity Summit, San Diego
2017
Connected Medication Management Strategy — End-to-End Platform Architecture
HIC Health Informatics Conference, Brisbane, Australia
View Conference ↗
2014
Blurred Lines in Healthcare Technology
AAMI BI&T Blog — On the convergence of IT, biomedical engineering, and clinical workflow
The Conversation Starts Here

If this argument
resonates with the problem
you are trying to solve —

I am selectively available for board roles, strategic advisory engagements, and investment due diligence in AI-enabled healthcare technology. The right conversation is the one where deep domain experience actually changes the outcome.

✉ danpettus@outlook.com ↗ LinkedIn Profile Murrieta, CA · Board · Advisory · Investment Counsel

Responses are personal and typically within 48 hours. All inquiries are held in strict confidence.